Trade Sage Therapeutics, Inc. - SAGE CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.05 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023346% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001124% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 6.88 |
| Open | 6.82 |
| 1-Year Change | -73.68% |
| Day's Range | 6.82 - 6.99 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Jan 21, 2025 | 6.88 | -0.13 | -1.85% | 7.01 | 7.07 | 6.67 |
| Jan 17, 2025 | 7.00 | 0.04 | 0.57% | 6.96 | 7.15 | 6.83 |
| Jan 16, 2025 | 6.94 | -0.27 | -3.74% | 7.21 | 7.23 | 6.71 |
| Jan 15, 2025 | 7.24 | -0.18 | -2.43% | 7.42 | 7.53 | 7.17 |
| Jan 14, 2025 | 7.40 | -0.09 | -1.20% | 7.49 | 7.57 | 7.37 |
| Jan 13, 2025 | 7.47 | -0.06 | -0.80% | 7.53 | 7.85 | 7.33 |
| Jan 10, 2025 | 5.53 | -0.01 | -0.18% | 5.54 | 5.66 | 5.41 |
| Jan 8, 2025 | 5.80 | -0.09 | -1.53% | 5.89 | 6.02 | 5.68 |
| Jan 7, 2025 | 5.94 | -0.21 | -3.41% | 6.15 | 6.48 | 5.93 |
| Jan 6, 2025 | 6.17 | 0.04 | 0.65% | 6.13 | 6.49 | 6.05 |
| Jan 3, 2025 | 6.11 | 0.37 | 6.45% | 5.74 | 6.11 | 5.74 |
| Jan 2, 2025 | 5.74 | 0.33 | 6.10% | 5.41 | 5.83 | 5.41 |
| Dec 31, 2024 | 5.39 | 0.02 | 0.37% | 5.37 | 5.48 | 5.26 |
| Dec 30, 2024 | 5.40 | 0.07 | 1.31% | 5.33 | 5.45 | 5.20 |
| Dec 27, 2024 | 5.50 | -0.13 | -2.31% | 5.63 | 5.92 | 5.31 |
| Dec 26, 2024 | 5.70 | 0.29 | 5.36% | 5.41 | 5.76 | 5.21 |
| Dec 24, 2024 | 5.44 | 0.12 | 2.26% | 5.32 | 5.47 | 5.04 |
| Dec 23, 2024 | 5.40 | -0.16 | -2.88% | 5.56 | 5.73 | 5.32 |
| Dec 20, 2024 | 5.59 | 0.62 | 12.47% | 4.97 | 5.59 | 4.90 |
| Dec 19, 2024 | 4.98 | -0.07 | -1.39% | 5.05 | 5.10 | 4.90 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Sage Therapeutic Company profile
About SAGE Therapeutics Inc
SAGE Therapeutics, Inc. is a biopharmaceutical company that is focused on developing and commercializing medicines with debilitating disorders of the brain. The Company's product, ZULRESSO (brexanolone) CIV injection, is for the treatment of postpartum depression (PPD), in adults. The Company's products also include ZULRESSO (Brexanolone) CIV Injection, Zuranolone (SAGE-217), SAGE-324 and SAGE-718. Its next advanced product candidate is SAGE-217, is an oral compound that is in Phase III clinical development in PPD and depressive disorder (MDD). Zuranolone is a neuroactive steroid that, like brexanolone, is a positive allosteric modulator of GABAA receptors, targeting both synaptic and extrasynaptic GABAA receptors. SAGE-324 is a GABAA receptor positive allosteric modulator intended for chronic oral dosing and conducting a placebo-controlled Phase II clinical trial evaluating the safety and efficacy of SAGE-324 in the treatment of essential tremor.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, SAGE Therapeutics Inc revenues decreased 99% to $6.3M. Net loss totaled $457.9M vs. income of $606.1M. Revenues reflect Collaboration revenue decrease from $1.11B to $0K, Product decrease of 6% to $6.3M. Net loss reflects Stock-based Compensation in R&D increase of 17% to $49.7M (expense), Stock-based Compensation in SGA increase of 6% to $54.9M (expense), Other income (expense).
Equity composition
Common Stock, $0.0001 Par, 07/14, auth. 120M shares,. 24,961,926 issd,. Insiders owns approx. 20.03%.
| Industry: | Bio Therapeutic Drugs |
215 1st St
CAMBRIDGE
MASSACHUSETTS 02142
US
News
MELANIA coin ($MELANIA) price prediction: Third party price target
Read our MELANIA crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts.
11:33, 22 January 2025
TRUMP coin ($TRUMP) price prediction: third-party price target
Read our TRUMP crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:52, 22 January 2025
Ethereum price prediction: Third party data round up
What is the outlook for ETH as a long-term investment?
16:37, 7 January 2025
Euro forecast: third party data roundup
In 2024, the euro’s outlook appeared more stable. Read on for our 2025 and beyond insights.
12:40, 31 December 2024
Pi Network coin price prediction: Third party price target
Discover the Pi Network coin price predictions for 2025 onward, with analyst outlooks, price targets and CFDs trading strategies on Capital.com
13:51, 13 December 2024
Projected US interest rates in 5 years: Third party round up
As the US central bank starts its cutting cycle, what are the projected interest rates in 5 years?
14:28, 12 December 2024
Projected UK interest rates in 5 years
Bank of England (BoE) cut rates for the first time in August 2024, with further easing expected in the coming months. But how low are rates likely to go?
11:20, 12 December 2024People also watch
Still looking for a broker you can trust?
Join the 680,000+ traders worldwide that chose to trade with Capital.com